![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » NASDAQ DEAL PRECURSOR TO IPO FOR CAMBRIDGE MEDICAL DEVICES COMPANY?
NASDAQ DEAL PRECURSOR TO IPO FOR CAMBRIDGE MEDICAL DEVICES COMPANY?
July 26, 2006
A Cambridge company developing technology that could save lives in intensive care units has signed a breakthrough commercialisation deal that could spell an imminent IPO. Sphere Medical the result of a joint venture between the Generics Group
in Harston and Siemens has penned the deal with NASDAQ listed Analogic
Corporation, a designer and manufacturer of hi-tech health systems. Analogic is
a well-known global innovator in CT, ultrasound and MRI scanning as well as patient
monitoring and its technology is integrated by OEMs.
Business
Weekly (UK)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct